Portfoliotracker

COMPASS Pathways plc

CMPS · NASDAQGS · Healthcare Medical Care Facilities 0/100 E

8,270 $
▼ −0,740 (−8,21 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 13:31
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score0 / 100 Market cap1,34 mld. $ P/E– Forward P/E-5,7 P/S– P/B9,5 EV/EBITDA– Dividend yield– FCF yield-11,99 % EPS-2,34 $ Net margin0,0 % Return on equity-296,5 % Beta2,41 Debt / equity0,38
52-week range 4,88 to 15,87
3-month average volume3,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Employees
156
Country
United Kingdom
Fiscal year end
31. 12.
Data since
18. 9. 2020

Explore further

Similar companies DFTXHELPGHRS

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account